Treating human leukemia with a Diabetic pill: Acarbose, an anti-diabetic drug used to treat non-insulin-dependent Diabetes Mellitus, suppresses the expression of a proto-oncogene mixed-lineage-AF4 via up regulation of its target gene, 18/March/2014, 12.07 am

Treating human leukemia with a Diabetic pill: Acarbose, an anti-diabetic drug used to treat non-insulin-dependent Diabetes Mellitus, suppresses the expression of a proto-oncogene mixed-lineage-AF4 via up regulation of its target gene, 18/March/2014, 12.07 am

Treating human leukemia with a Diabetic pill: Acarbose, an anti-diabetic drug used to treat non-insulin-dependent Diabetes Mellitus, suppresses the expression of a proto-oncogene mixed-lineage-AF4 via up regulation of its target gene, 18/March/2014, 12.07 am 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated by: Dr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To cite: Boominathan, Treating human leukemia with a Diabetic pill: Acarbose, an anti-diabetic drug used to treat non-insulin-dependent Diabetes Mellitus, suppresses the expression of a proto-oncogene mixed-lineage-AF4  via up regulation of its target gene, 18/March/2014, 12.07 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Share
Start Typing